CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 31, 2021		94,389,543
Balance at beginning of period at Dec. 31, 2021	$ 2,886,311	$ 929	$ 2,351,294	$ 541,950	$ (7,862)
Increase (Decrease) in Stockholders' Equity
Net income	66,904			66,904
Comprehensive income (loss)	(136,371)				(136,371)
Cash dividends declared	(31,142)			(31,142)
Dividend equivalents declared	0		121	(121)
Share-based compensation expense	5,530		5,530
Issuance of restricted stock, net (in shares)		714,783
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(175,219)
Restricted stock surrendered and canceled	(8,548)		(8,548)
Exercise of stock options (in shares)		16,742
Exercise of stock options	334		334
Balance at end of period (in shares) at Mar. 31, 2022		94,945,849
Balance at end of period at Mar. 31, 2022	$ 2,783,018	$ 933	2,348,727	577,591	(144,233)
Balance at beginning of period (in shares) at Dec. 31, 2022	95,021,760	95,021,760
Balance at beginning of period at Dec. 31, 2022	$ 2,798,389	$ 933	2,362,663	700,040	(265,247)
Increase (Decrease) in Stockholders' Equity
Net income	62,562			62,562
Comprehensive income (loss)	2,518				2,518
Cash dividends declared	(31,357)			(31,357)
Dividend equivalents declared	0		122	(122)
Share-based compensation expense	4,729		4,729
Issuance of restricted stock, net (in shares)		834,724
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(142,175)
Restricted stock surrendered and canceled	(5,691)		(5,691)
Exercise of stock options (in shares)		468
Exercise of stock options	$ 11		11
Balance at end of period (in shares) at Mar. 31, 2023	95,714,777	95,714,777
Balance at end of period at Mar. 31, 2023	$ 2,831,161	$ 937	$ 2,361,830	$ 731,123	$ (262,729)